Targeting reactive nitrogen species suppresses hereditary pancreatic cancer

Area of Science:

• Oncology
• Genetics
• Biochemistry

Background:

• Germline mutations in BRCA2 are associated with hereditary pancreatic cancer.
• The precise mechanisms by which BRCA2 deficiency drives pancreatic tumorigenesis are not fully understood.

Purpose of the Study:

• To investigate the role of reactive nitrogen species (RNS) in BRCA2-deficient pancreatic tumorigenesis.
• To explore RNS suppression as a potential therapeutic strategy for pancreatic cancer prevention.

Main Methods:

• Utilized a mouse model of Brca2-deficiency-induced pancreatic tumors.
• Assessed RNS levels, DNA damage (including double-strand breaks), and genomic instability.
• Administered the antioxidant tempol to evaluate its effects on RNS, DNA damage, and tumor development.

Main Results:

• Elevated levels of RNS, specifically nitrite, were detected in precancerous pancreases of Brca2-deficient mice.
• Excess RNS induced significant DNA damage and genomic instability in the absence of functional Brca2.
• Tempol treatment effectively suppressed RNS, reduced DNA lesions, and delayed the onset of pancreatic cancer.

Conclusions:

• Excessive RNS act as a non-genetic driving force in Brca2-deficiency-induced pancreatic tumors.
• RNS suppression presents a promising strategy for pancreatic cancer prevention in individuals with BRCA2 mutations.